First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer

NCT01723475 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

BIOLOGICAL: BAY2010112
BIOLOGICAL: BAY2010112

Sponsor

Bayer